The North America Craniomaxillofacial Devices Market would witness market growth of 8.6% CAGR during the forecast period (2022-2028).
In the market for craniomaxillofacial (CMF) devices and equipment, there has been a recent uptick in the prevalence of the use of 3D Printing technology. The technique known as 3D printing is a method for fabricating intricate structures by superimposing successively thinner layers on top of one another and extruding intricate edging features. When doing cranial and maxillofacial reconstructive surgery, the use of 3D biological models is extraordinarily beneficial.
Utilizing the 3D modeling approach provided by the 3D models would be beneficial to the preoperative planning process. For instance, Renishaw Company has developed patient-specific laser implants that are 3D-printed metal CMF implants with exceptional strength and flexibility. These laser implants were made using lasers.
Patients typically have craniomaxillofacial surgery when they require surgery on their face or cranial bones as a result of trauma-related fractures or other craniomaxillofacial injuries. This kind of surgery is known as craniomaxillofacial surgery. Craniomaxillofacial devices are utilized in the field of aesthetics as well as in the field of facial reconstruction. The field of neurosurgery, together with orthognathic and dental surgery, as well as plastic surgery, are the most common applications for the devices.
According to the statistics that were supplied by the government of Canada in April 2010, in Canada, around 57% of children and adolescents between the ages of 6 and 11 have or have had a cavity. 59% of people between the ages of 12 and 19 have or have had a cavity in their teeth. In addition, a significant number of individuals in the United States make use of both over-the-counter and prescription medications. These drugs induce dry mouth, which leads to decreased saliva production and increases the risk of dental cavities and other oral problems. Because of all of these issues, there is a growing need across the area for improved oral healthcare services. Therefore, a rise in the use of dental bone grafts and substitutes would also occur in the North American area, which would boost the market expansion.
The US market dominated the North America Craniomaxillofacial Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,325.1 million by 2028. The Canada market is poised to grow at a CAGR of 11.1% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 10.1% during (2022 - 2028).
Based on Material, the market is segmented into Metal, Bio Absorbable, Ceramics, and Total. Based on Application, the market is segmented into Orthognathic & Dental Surgery, Neurosurgery & ENT, and Plastic Surgery. Based on Product, the market is segmented into CMF Plate & Screw Fixation, Cranial Flap Fixation, CMF Distraction, Temporomandibular Joint, Replacement, Thoracic Fixation, and Bone Graft Substitute. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Craniomaxillofacial Devices Market is Predict to reach $2.9 Billion by 2028, at a CAGR of 9.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Stryker Corporation, Johnson & Johnson (DePuy Synthes), Medtronic PLC, B. Braun Melsungen AG, Renishaw PLC, Medartis AG, Zimmer Biomet Holdings, Inc., Xilloc Medical B.V, Synimed, and KLS Martin Group.
By Material
By Application
By Product
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 